Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.02
HCA's Cash to Debt is ranked lower than
54% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. HCA: 0.02 )
HCA' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.02

Equity to Asset -0.29
HCA's Equity to Asset is ranked lower than
57% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. HCA: -0.29 )
HCA' s 10-Year Equity to Asset Range
Min: -0.5   Max: 0.41
Current: -0.29

-0.5
0.41
Interest Coverage 1.59
HCA's Interest Coverage is ranked higher than
53% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 6.48 vs. HCA: 1.59 )
HCA' s 10-Year Interest Coverage Range
Min: 1.32   Max: 6.08
Current: 1.59

1.32
6.08
F-Score: 6
Z-Score: 1.31
M-Score: -2.71
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 8.62
HCA's Operating margin (%) is ranked higher than
74% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 9.71 vs. HCA: 8.62 )
HCA' s 10-Year Operating margin (%) Range
Min: 5.48   Max: 15.86
Current: 8.62

5.48
15.86
Net-margin (%) 4.55
HCA's Net-margin (%) is ranked higher than
73% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. HCA: 4.55 )
HCA' s 10-Year Net-margin (%) Range
Min: -1.62   Max: 8.3
Current: 4.55

-1.62
8.3
ROA (%) 5.40
HCA's ROA (%) is ranked higher than
79% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. HCA: 5.40 )
HCA' s 10-Year ROA (%) Range
Min: -1.39   Max: 9.16
Current: 5.4

-1.39
9.16
ROC (Joel Greenblatt) (%) 18.04
HCA's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 17.97 vs. HCA: 18.04 )
HCA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.66   Max: 31.35
Current: 18.04

8.66
31.35
Revenue Growth (%) 4.90
HCA's Revenue Growth (%) is ranked higher than
69% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. HCA: 4.90 )
HCA' s 10-Year Revenue Growth (%) Range
Min: -7.8   Max: 24.3
Current: 4.9

-7.8
24.3
EBITDA Growth (%) 2.50
HCA's EBITDA Growth (%) is ranked higher than
69% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. HCA: 2.50 )
HCA' s 10-Year EBITDA Growth (%) Range
Min: -18.8   Max: 37.7
Current: 2.5

-18.8
37.7
EPS Growth (%) 6.90
HCA's EPS Growth (%) is ranked higher than
72% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. HCA: 6.90 )
HCA' s 10-Year EPS Growth (%) Range
Min: 0   Max: 88.4
Current: 6.9

0
88.4
» HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

HCA Guru Trades in Q2 2013

Jim Simons 428,900 sh (New)
Steven Cohen 1,674,756 sh (+19630.9%)
Joel Greenblatt 126,942 sh (+20.31%)
Jeremy Grantham 161,266 sh (+13.16%)
Vanguard Health Care Fund 3,771,600 sh (+10.93%)
Larry Robbins 9,841,713 sh (+10.81%)
Jean-Marie Eveillard 1,605,839 sh (+6.38%)
John Griffin 4,920,000 sh (unchged)
Ken Heebner Sold Out
Julian Robertson Sold Out
Caxton Associates Sold Out
John Paulson 3,403,919 sh (-0.32%)
David Tepper 3,923,082 sh (-9.3%)
Louis Moore Bacon 250,000 sh (-16.67%)
Lee Ainslie 5,745,514 sh (-19.67%)
Paul Tudor Jones 165,400 sh (-34.96%)
» More
Q3 2013

HCA Guru Trades in Q3 2013

Leon Cooperman 1,915,500 sh (New)
John Burbank 334,177 sh (New)
Andreas Halvorsen 2,783,331 sh (New)
Paul Tudor Jones 385,000 sh (+132.77%)
David Tepper 4,573,082 sh (+16.57%)
Larry Robbins 10,341,713 sh (+5.08%)
John Paulson 3,403,919 sh (unchged)
Caxton Associates 200,000 sh (unchged)
Vanguard Health Care Fund 3,771,600 sh (unchged)
Jim Simons Sold Out
Jean-Marie Eveillard Sold Out
Louis Moore Bacon Sold Out
Jeremy Grantham 134,051 sh (-16.88%)
John Griffin 3,790,000 sh (-22.97%)
Lee Ainslie 3,694,317 sh (-35.7%)
Steven Cohen 1,064,939 sh (-36.41%)
Joel Greenblatt 58,754 sh (-53.72%)
» More
Q4 2013

HCA Guru Trades in Q4 2013

David Dreman 1,177 sh (New)
Caxton Associates 900,000 sh (New)
Manning & Napier Advisors, Inc 853,355 sh (New)
Louis Moore Bacon 125,000 sh (New)
Joel Greenblatt 138,999 sh (+136.58%)
Vanguard Health Care Fund 6,746,600 sh (+78.88%)
Lee Ainslie 5,090,099 sh (+37.78%)
Leon Cooperman 2,532,000 sh (+32.18%)
Larry Robbins 12,841,713 sh (+24.17%)
David Tepper 5,101,382 sh (+11.55%)
John Paulson 3,403,919 sh (unchged)
John Burbank Sold Out
Andreas Halvorsen 2,654,617 sh (-4.62%)
Jeremy Grantham 115,513 sh (-13.83%)
John Griffin 3,065,000 sh (-19.13%)
Paul Tudor Jones 14,227 sh (-96.3%)
Steven Cohen 16,094 sh (-98.49%)
» More
Q1 2014

HCA Guru Trades in Q1 2014

Manning & Napier Advisors, Inc 837,125 sh (-1.9%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2013-12-31 Add 37.78%0.85%$43.78 - $48.54 $ 50.49%5090099
John Burbank 2013-12-31 Sold Out 0.46%$43.78 - $48.54 $ 50.49%0
Vanguard Health Care Fund 2013-12-31 Add 78.88%0.44%$43.78 - $48.54 $ 50.49%6746600
Leon Cooperman 2013-12-31 Add 32.18%0.41%$43.78 - $48.54 $ 50.49%2532000
John Griffin 2013-12-31 Reduce -19.13%0.36%$43.78 - $48.54 $ 50.49%3065000
Joel Greenblatt 2013-12-31 Add 136.58%0.09%$43.78 - $48.54 $ 50.49%138999
David Dreman 2013-12-31 New Buy$43.78 - $48.54 $ 50.49%1177
Leon Cooperman 2013-09-30 New Buy1.2%$35.49 - $42.75 $ 50.429%1915500
Lee Ainslie 2013-09-30 Reduce -35.7%1%$35.49 - $42.75 $ 50.429%3694317
John Griffin 2013-09-30 Reduce -22.97%0.48%$35.49 - $42.75 $ 50.429%3790000
John Burbank 2013-09-30 New Buy0.46%$35.49 - $42.75 $ 50.429%334177
Jean-Marie Eveillard 2013-09-30 Sold Out 0.18%$35.49 - $42.75 $ 50.429%0
Joel Greenblatt 2013-09-30 Reduce -53.72%0.11%$35.49 - $42.75 $ 50.429%58754
Julian Robertson 2013-06-30 Sold Out 3.2%$36.06 - $41.4 $ 50.430%0
Lee Ainslie 2013-06-30 Reduce -19.67%0.75%$36.06 - $41.4 $ 50.430%5745514
Joel Greenblatt 2013-06-30 Add 20.31%0.03%$36.06 - $41.4 $ 50.430%126942
Lee Ainslie 2013-03-31 New Buy3.8%$30.17 - $40.63 $ 50.438%7152046
John Paulson 2013-03-31 Reduce -50.86%0.66%$30.17 - $40.63 $ 50.438%3414926
John Griffin 2013-03-31 Add 21.78%0.45%$30.17 - $40.63 $ 50.438%4920000
Jean-Marie Eveillard 2013-03-31 Reduce -66.87%0.33%$30.17 - $40.63 $ 50.438%1509464
Joel Greenblatt 2013-03-31 Add 247.01%0.16%$30.17 - $40.63 $ 50.438%105512
John Burbank 2013-03-31 Sold Out 0.12%$30.17 - $40.63 $ 50.438%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about HCA Holdings Inc

Manning & Napier New Stocks of Fourth Quarter
Manning & Napier is an investment management company operating managed accounts, mutual funds and collective investment trust funds. As of Nov. 30, 2013, the firm has $50.4 billion in assets under management. Manning & Napier has a team approach to investing, is price conscious about stock selection, and focuses on positive absolute returns by avoiding over-valued areas. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 15.00
HCA's P/E(ttm) is ranked higher than
89% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 21.80 vs. HCA: 15.00 )
HCA' s 10-Year P/E(ttm) Range
Min: 3.87   Max: 16.12
Current: 15

3.87
16.12
P/S 0.68
HCA's P/S is ranked higher than
79% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. HCA: 0.68 )
HCA' s 10-Year P/S Range
Min: 0.32   Max: 0.69
Current: 0.68

0.32
0.69
PFCF 13.37
HCA's PFCF is ranked higher than
79% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 15.52 vs. HCA: 13.37 )
HCA' s 10-Year PFCF Range
Min: 4.08   Max: 13.64
Current: 13.37

4.08
13.64
EV-to-EBIT 14.41
HCA's EV-to-EBIT is ranked higher than
73% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 17.77 vs. HCA: 14.41 )
HCA' s 10-Year EV-to-EBIT Range
Min: 7.9   Max: 14.9
Current: 14.41

7.9
14.9
PEG 5.00
HCA's PEG is ranked lower than
52% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 1.93 vs. HCA: 5.00 )
HCA' s 10-Year PEG Range
Min: 0.37   Max: 0.97
Current: 5

0.37
0.97
Shiller P/E 12.40
HCA's Shiller P/E is ranked higher than
93% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 24.97 vs. HCA: 12.40 )
HCA' s 10-Year Shiller P/E Range
Min: 5.4   Max: 12.66
Current: 12.4

5.4
12.66

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 4.32
HCA's Price/DCF (Projected) is ranked lower than
62% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. HCA: 4.32 )
HCA' s 10-Year Price/DCF (Projected) Range
Min: 4.09   Max: 17.96
Current: 4.32

4.09
17.96
Price/Median PS Value 1.36
HCA's Price/Median PS Value is ranked lower than
51% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. HCA: 1.36 )
HCA' s 10-Year Price/Median PS Value Range
Min: 0.71   Max: 1.29
Current: 1.36

0.71
1.29
Earnings Yield (Greenblatt) 6.90
HCA's Earnings Yield (Greenblatt) is ranked higher than
73% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 5.30 vs. HCA: 6.90 )
HCA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.7   Max: 12.7
Current: 6.9

6.7
12.7
Forward Rate of Return (Yacktman) -15.06
HCA's Forward Rate of Return (Yacktman) is ranked lower than
51% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. HCA: -15.06 )
HCA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13.2   Max: 44.9
Current: -15.06

-13.2
44.9

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:2BH.Germany
HCA Holdings, Inc. was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. HCA Inc. completed its merger with Hercules Acquisition Corporation, pursuant to which the Company was acquired by Hercules Holding II, LLC ('Hercules Holding'), a Delaware limited liability Company owned by a private investor group. The Company owns and operates hospitals and related health care entities. The Company's general, acute care hospitals provide a range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers, and rehabilitation facilities. The Company's psychiatric hospitals provide a range of mental health care services through inpatient, partial hospitalization, and outpatient settings. Health Care Facilities The Company owns, manages, or operates hospitals; freestanding surgery centers; diagnostic and imaging centers; radiation and oncology therapy centers; rehabilitation and physical therapy centers; and various other facilities. the company owned and operated 156 general, acute care hospitals with 41,198 licensed beds. Majority of its general, acute care hospitals provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services. The general, acute care hospitals also provide outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The Company operated 5 psychiatric hospitals with 506 licensed beds. Its psychiatric hospitals provide therapeutic programs, including child, adolescent and adult psychiatric care, adult and adolescent alcohol and drug abuse treatment and counseling. The Company also operates outpatient health care facilities which include freestanding ambulatory surgery centers, freestanding emergency care facilities, diagnostic and imaging centers, outpatient rehabilitation and physical therapy centers, outpatient radiation and oncology therapy centers, and various other facilities. the company's affiliates provide various management services to its health care facilities, including patient safety programs; ethics and compliance programs; national supply contracts; equipment purchasing and leasing contracts; accounting, financial, and clinical systems; governmental reimbursement assistance; construction planning and coordination; information technology systems and solutions; legal counsel; human resources services; and internal audit services.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide